The following table contains a list of scientific publications
which are the basis for the various statements and claims made about
hereditary ovarian cancer on this website. The articles have been
organized by subject, as indicated in the list of 8 subcategories
below. To search for articles in a specific subcategory, simply
click on the item in the list below, and you will be taken to the
proper location within the table. If you find an article that you
would like to know more about, click on the title of the article,
and you will be taken to a detailed summary of the article, as it
appears on the PubMed scientific literature site maintained by the
National Library of Medicine.
| [to top of page] |
| OVARIAN
CANCER GENETICS, BRCA1, BRCA2 |
| Author |
Article Title |
Journal |
| Easton DF, et al |
Genetic
linkage analysis in familial breast and ovarian cancer. Results
from 214 families |
American Journal of Human Genetics 1993 |
| Miki Y, et al |
A
strong candidate for the breast-ovarian cancer susceptibility
gene BRCA1 |
Science 1994 |
| Wooster R, et al |
Identification
of the breast cancer susceptibility gene BRCA2 |
Nature 1995 |
| Modan B, et al |
Parity,
oral contraceptives and the risk of ovarian cancer among carriers
and non-carriers of a BRCA1 or a BRCA2 mutation |
New England Journal of Medicine 2001 |
| Stratton JF, et al |
The
genetic epidemiology of early-onset ovarian cancer – A population-based
study |
American Journal of Human Genetics 1999 |
| Moslehi R, et al |
BRCA1
and BRCA2 mutations in Ashkenazi Jewish women with ovarian cancer |
American Journal of Human Genetics 2000 |
| Ford D, et al |
Estimates
of the gene frequency of BRCA1 and its contribution to breast
and ovarian cancer incidence |
American Journal of Human Genetics 1995 |
| Breast Cancer Linkage Consortium |
Cancer
risks in BRCA2 mutation carriers |
Journal of the National Cancer Institute 1999 |
| Menczer J, et al |
Familial
ovarian cancer in Israeli Jewish women |
Obstetrics & Gynecology 1991 |
| Burke W, et al |
Recommendations
for follow-up care of individuals with inherited predisposition
to cancer |
JAMA 1997 |
| Amos CI, et al |
Age
at onset for familial epithelial ovarian cancer |
JAMA 1992 |
| Stratton JF, et al |
A
systematic review and meta-analysis of family history and risk
of ovarian cancer |
British Journal of Obstetrics and Gyneacology 1998 |
| Struewing J, et al |
The
risk associated with specific mutations of BRCA1 and BRCA2 among
Ashkenazi Jews |
New England Journal of Medicine 1997 |
| Hartge P, et al |
The
prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi
Jews |
American Journal of Human Genetics 1999 |
| Parmigiani G, et al |
Determining
carrier probabilities for breast cancer susceptibility genes
BRCA1 and BRCA2 |
American Journal of Human Genetics 1998 |
| Colgan TJ, et al |
Occult
carcinoma in prophylactic oophorectomy specimens: prevalence
and association with BRCA germline mutation status |
American Journal of Surgical Pathology 2001 |
| Werness BA, et al |
Altered
surface and cyst epithelium of ovaries removed prophylactically
from women with a family history of ovarian cancer |
Human Pathology 1999 |
| Werness BA, et al |
Ovarian
carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity
at BRCA1 and TP53 |
Journal of the National Cancer Institute 2000 |
| Thompson DJ, et al |
Cancer
incidence in BRCA1 mutation carriers |
Journal of the National Cancer Institute 2002 |
| Watson P, et al |
Extracolonic
cancer in hereditary nonpolyposis colorectal cancer |
Cancer 1993 |
| Nicolaides NC, et al |
Mutations
of two PMS homologues in hereditary nonpolyposis colorectal
cancer |
Nature 1994 |
| [to top of page] |
| RISK-REDUCING SURGERY |
| Author |
Article Title |
Journal |
| Rebbeck, TR |
Prophylactic
oophorectomy BRCA1 and BRCA2 mutation carriers |
European Journal of Cancer 2002 |
| Kerlikowske K, et al |
Should
women with familial ovarian cancer undergo prophylactic oophorectomy? |
Obstetrics & Gynecology 1992 |
| Quillin JM, et al |
Preventive
gynecologic surgery for BRCA1/2 carriers -- Information for
decision-making |
Gynecologic Oncology 2001 |
| Rebbeck TR, et al |
Breast
cancer risk after bilateral prophylactic oophorectomy in BRCA1
mutation carriers |
Journal of the National Cancer Institute 1999 |
| Salazar H, et al |
Microscopic
benign and invasive malignant neoplasms and a cancer-prone phenotype
in prophylactic oophorectomies |
Journal of the National Cancer Institute 1996 |
| Eltabbakh GH, et al |
Laparoscopic
management of women with a family history of ovarian cancer |
Journal of Surgical Oncology 1999 |
| Lu KH, et al |
Occult
ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing
prophylactic oophorectomy |
Journal of Clinical Oncology 2000 |
| Morice P, et al |
Laparoscopic
prophylactic oophorectomy in women with inherited risk of ovarian
cancer |
European Journal of Gynaecological Oncology 1999 |
| Struewing JP, et al |
Prophylactic
oophorectomy in inherited breast/ovarian cancer. |
Journal of the National Cancer Institute Monographs 1995 |
| Schrag D, et al |
Decision
analysis – Effects of prophylactic mastectomy and oophorectomy
on life expectancy among women with BRCA1 or BRCA2 mutations |
New England Journal of Medicine 1997 |
| Nguyen HN, et al |
Ovarian
carcinoma – A review of the significance of familial risk factors
and the role of prophylactic oophorectomy in cancer prevention |
Cancer 1994 |
| Elit L, et al |
Prophylactic
oophorectomy in Ontario |
Familial Cancer 2001 |
| Colgan TJ, et al |
Occult
carcinoma in prophylactic oophorectomy specimens: prevalence
and association with BRCA germline mutation status |
American Journal of Surgical Pathology 2001 |
| Salazar H, et al |
Microscopic
benign and invasive malignant neoplasms and a cancer-prone phenotype
in prophylactic oophorectomies |
Journal of the National Cancer Institute 1996 |
| Hankinson SE, et al |
Tubal
ligation, hysterectomy and the risk of ovarian cancer – A prospective
study |
JAMA 1993 |
| Rosenblatt KA, et al |
Reduced
risk of ovarian cancer in women with tubal ligation or hysterectomy |
Cancer Epidemiology Biomarkers Prevention 1996 |
| Miracle-McMahill HL, et al |
Tubal
ligation and fatal ovarian cancer in a large prospective cohort
study |
American Journal of Epidemiology 1997 |
| Green A, et al |
Tubal
sterilization, hysterectomy and decreased risk of ovarian cancer |
International Journal of Cancer 1997 |
| Krieger N, et al |
Surgical
procedures associated with risk of ovarian cancer |
International Journal of Epidemiology 1997 |
| Narod SA, et al |
Tubal
ligation and risk of ovarian cancer in carriers of BRCA1 or
BRCA2 mutations – a case-control study |
Lancet 2001 |
| [to top of page] |
| OVARIAN CANCER SCREENING |
| Author |
Article Title |
Journal |
| Jacobs IJ, et al |
Screening
for ovarian cancer – A Pilot, randomized controlled trial |
Lancet 1999 |
| Skates SJ, et al |
Toward
an optimal algorithm for ovarian cancer screening with longitudinal
tumor makers |
Cancer 1995 |
| Eltabbakh GH, et al |
Laparoscopic
management of women with a family history of ovarian cancer |
Journal of Surgical Oncology 1999 |
| Xu Y, et al |
Lysophosphatidic
acid as a potential biomarker for ovarian and other gynecologic
cancers |
JAMA 1998 |
| Skates S, et al |
Screening
based on the risk of cancer calculation from Bayesian hierarchical
change-point and mixture models of longitudinalmarkers |
Journal of the American Statistical Association 2001 |
| Wardle FJ, et al |
Psychological
impact of screening for familiar ovarian cancer |
Journal of the National Cancer Institute 1993 |
| Wardle J, et al |
The
psychological costs of screening for cancer |
Journal of Psychosomatic Research 1992 |
| Einhorn N, et al |
Prospective
evaluation of serum CA 125 levels for early detection of ovarian
cancer |
Obstetrics & Gynecology 1992 |
| Cohen L, et al |
Ultrasound
and ovarian cancer |
Cancer Treatment Research 2002 |
| [to top of page] |
| OVARIAN CANCER RISK FACTORS |
| Author |
Article Title |
Journal |
| Whittemore AS, et al |
Characteristics
relating to ovarian cancer risk: collaborative analysis of 12
US case-control studies. II. Invasive epithelial ovarian cancers
in white women. Collaborative Ovarian Cancer Group |
American Journal of Epidemiology 1992 |
| Ness RB, et al |
Risks
of ovarian cancer in relation to estrogen and progestin dose
and use characteristics of oral contraceptives |
American Journal of Epidemiology 2000 |
| Narod SA, et al |
Oral
contraceptives and the risk of hereditary ovarian cancer |
New England Journal of Medicine 1998 |
| Modan B, et al |
Parity,
oral contraceptives and the risk of ovarian cancer among carriers
and non-carriers of a BRCA1 or a BRCA2 mutation |
New England Journal of Medicine 2001 |
| Nguyen HN, et al |
Ovarian
carcinoma – A review of the significance of familial risk factors
and the role of prophylactic oophorectomy in cancer prevention |
Cancer 1994 |
| Stratton JF, et al |
A
systematic review and meta-analysis of family history and risk
of ovarian cancer |
British Journal of Obstetrics and Gyneacology 1998 |
| Whittemore AS, et al |
Characteristics
related to ovarian cancer risk: Collaborative analysis of 12
US case-control studies. II – Invasive epithelial ovarian cancer
in white women |
American Journal of Epidemiology 1992 |
| [to top of page] |
| QUALITY OF LIFE, PSYCHOSOCIAL
ISSUES |
| Author |
Article Title |
Journal |
| Kash KM, et al |
Psychological
distress and surveillance behaviors of women with a family history
of breast cancer |
Journal of the National Cancer Institute 1992 |
| Lerman C, et al |
Mammography
adherence and psychological distress among women at risk for
breast cancer |
Journal of the National Cancer Institute 1993; 85:1074-80
|
| Wardle FJ, et al |
Psychological
impact of screening for familiar ovarian cancer |
Journal of the National Cancer Institute 1993 |
| Wardle J, et al |
The
psychological costs of screening for cancer |
Journal of Psychosomatic Research 1992 |
| Swisher EM, et al |
Prophylactic
oophorectomy and ovarian cancer surveillance in women at high
risk of ovarian cancer: patient perceptions and satisfaction. |
Journal of Reproductive Medicine 2001 |
| Ware JE, et al |
The
MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual
framework and item selection |
Medical Care 1992 |
| McHorney CA, et al |
The
MOS-36-item Short Form Health Survey (SF-36): II. Psychometric
and clinical tests of validity in measuring physical and mental
health constructs |
Medical Care 1993 |
| Horowitz M, et al |
Impact
of Events Scale: A measure of subjective stress |
Psychosomatic Medicine 1979 |
| Lesko L, et al |
Long-term
psychological adjustment of acute leukemia survivors. Impact
of bone marrow transplantation versus conventional chemotherapy |
Psychosomatic Medicine 1992 |
| Cordova MJ, et al |
Frequency
and correlates of posttraumatic-stress-disorder-like symptoms
after treatment for breast cancer |
Psychosomatic Medicine 1995 |
| Cella DF, et al |
Psychological
adjustment to survival from Hodgkin’s Disease |
Journal of Consulting and Clinical Psychology 1986 |
| Robinson GE, et al |
Psychological
impact of screening for familial ovarian cancer - Reactions
to initial assessment |
Gynecologic Oncology 1997 |
| Thirlaway K, et al |
The
Sexual Activity Questionnaire - A measure of women’s sexual
functioning |
Quality of Life Research 1996 |
| Rosen R, et al |
The
Female Sexual Function Index (FSFI): A multidimensional self-report
instrument for the assessment of female sexual function |
Journal of Sex and Marital Therapy 2000 |
| Cella D, et al |
A
brief assessment of concerns associated with genetic testing
for cancer: the Multidimensional Impact of Cancer Risk Outcomes
(MICRO) questionnaire. |
Health Psychology 2002 |
| Fallowfield LJ, et al |
Assessment
of quality of life in women undergoing hormonal therapy for
breast cancer. Validation of an endocrine symptom subscale for
the FACT-B |
Breast Cancer Research and Treatment 1999 |
| Hulley S, et al |
Randomized
trial of estrogen plus progestin for secondary prevention of
coronary heart disease in postmenopausal women. Heart and Estrogen/progestin
Replacement Study (HERS) Research Group |
JAMA 1998 |
| [to top of page] |
| FALLOPIAN TUBE CANCER |
| Author |
Article Title |
Journal |
| Zweemer RP, et al |
Molecular
evidence linking primary cancer of the fallopian tube to BRCA1
germline mutations |
Gynecologic Oncology 2000 |
| Aziz S, et al |
A
genetic epidemiological study of carcinoma of the fallopian
tube |
Gynecologic Oncology 2001 |
| Alvarado-Cabrero I, et al |
Carcinoma
of the fallopian tube: a clinicopathological study of 105 cases
with observations on staging and prognostic factors |
Gynecologic Oncology 1999 |
| [to top of page] |
| PERITONEAL CANCER |
| Author |
Article Title |
Journal |
| Karlan BY, et al |
Peritoneal
serous papillary carcinoma – a phenotypic variant of familial
ovarian cancer: Implications for ovarian cancer screening |
American Journal of Obstetrics and Gynecology 1999 |
| Tobacman J, et al |
Intra-abdominal
carcinomatosis after risk-reducing salpingo-oophorectomy in
ovarian cancer prone families |
Lancet 1982 |
| Schoerge JO, et al |
BRCA1-related
papillary serous carcinoma of the peritoneum has a unique molecular
pathogenesis |
Cancer Research 2000 |
| Piver MS, et al |
Primary
peritoneal carcinoma after prophylactic oophorectomy in women
with a family history of ovarian cancer. A report from the Gilda
Radner Family Ovarian Cancer Registry |
Cancer 1993 |
| Bloss JD, et al |
Extra-ovarian
peritoneal serous papillary carcinoma: a case-control retrospective
comparison to papillary adenocarcinoma of the ovary |
Gynecologic Oncology 1993 |
| Muto MG, et al |
Evidence
for a multifocal origin of papillary serous carcinoma of the
peritoneum |
Cancer Research 1995 |
| [to top of page] |
| PRE-CANCEROUS CHANGES IN
THE OVARIES |
| Author |
Article Title |
Journal |
| Bell DA, et al |
Early
de novo ovarian carcinoma. A study of fourteen cases |
Cancer 1994 |
| Deligdisch L, et al |
Ovarian
dysplasia in epithelial inclusion cysts. A morphometric approach
using neural networks |
Cancer 1995 |
| Deligdisch L, et al |
Characterization
of ovarian dysplasia by interactive morphometry |
Cancer 1989 |
| Deligdisch L, et al |
Ovarian
dysplasia in prophylactic oophorectomy specimens: cytogenetic
and morphometric correlations |
Cancer 1999 |
| Sherman ME, et al |
Histopathologic
features of ovaries at increased risk for carcinoma. A case-control
analysis |
International Journal of Gynecological Pathology 1999 |
| Werness BA, et al |
Familial
ovarian cancer and early ovarian cancer: biologic, pathologic
and clinical features |
International Journal of Gynecological Pathology 2001 |
